We've found
184,457
clinical trials
We've found
184,457
clinical trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Other Clinical Trial
Updated: 12/31/1969
Clinical Investigation of New CI Delivery Models in an Adult Nucleus CI Population
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Healthy Clinical Trial
Updated: 10/2/2017
Metaplasticity in the Human Motor Cortex Experimental Design and Comparison of Motor Outcome Measure Sensitivity to Change
Status: Enrolling
Updated: 10/2/2017
Click here to add this to my saved trials

Severe Aplastic Anemia Clinical Trial
Updated: 12/31/1969
Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Severe Aplastic Anemia Clinical Trial
Updated: 12/31/1969
Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Severe Aplastic Anemia Clinical Trial
Updated: 12/31/1969
Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Scleroderma, Systemic Clinical Trial
Updated: 12/31/1969
Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Metastatic Pancreatic Cancer Clinical Trial
Updated: 12/31/1969
RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Parents Clinical Trial
Updated: 12/31/1969
Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Eosinophilic Esophagitis (EoE) Clinical Trial
Updated: 12/31/1969
Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Eosinophilic Esophagitis (EoE) Clinical Trial
Updated: 12/31/1969
Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Eosinophilic Esophagitis (EoE) Clinical Trial
Updated: 12/31/1969
Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Eosinophilic Esophagitis (EoE) Clinical Trial
Updated: 12/31/1969
Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Eosinophilic Esophagitis (EoE) Clinical Trial
Updated: 12/31/1969
Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Otolaryngology, Pharmacology / Toxicology Clinical Trial
Updated: 12/31/1969
Safer Food Allergy Management for Adolescents
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Healthy Volunteer Clinical Trial
Updated: 12/31/1969
Recruitment and Characterization of Healthy Research Volunteers for NIMH Intramural Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 10/6/2017
Virtual Reality Distraction During Pediatric Intravenous Line Placement
Status: Enrolling
Updated: 10/6/2017
Click here to add this to my saved trials

MRSA Clinical Trial
Updated: 12/31/1969
Retapamulin as a Decolonizing Agent for MRSA
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Nephrology / Urology, Other Clinical Trial
Updated: 12/31/1969
Prospective Research Rare Kidney Stones (ProRKS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
Extracellular RNA Markers of Liver Disease and Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
JBT-101 in Systemic Lupus Erythematosus (SLE)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
JBT-101 in Systemic Lupus Erythematosus (SLE)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
JBT-101 in Systemic Lupus Erythematosus (SLE)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Suspected or Documented Gram-negative Bacterial Infection Clinical Trial
Updated: 12/31/1969
A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Suspected or Documented Gram-negative Bacterial Infection Clinical Trial
Updated: 12/31/1969
A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Relapsing Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Diffuse Large B-Cell Lymphoma Clinical Trial
Updated: 12/31/1969
A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Diffuse Large B-Cell Lymphoma Clinical Trial
Updated: 12/31/1969
A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Diffuse Large B-Cell Lymphoma Clinical Trial
Updated: 12/31/1969
A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Diffuse Large B-Cell Lymphoma Clinical Trial
Updated: 12/31/1969
A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Diffuse Large B-Cell Lymphoma Clinical Trial
Updated: 12/31/1969
A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Diffuse Large B-Cell Lymphoma Clinical Trial
Updated: 12/31/1969
A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Diffuse Large B-Cell Lymphoma Clinical Trial
Updated: 12/31/1969
A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Myasthenia Gravis, Generalized Clinical Trial
Updated: 12/31/1969
Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 10/3/2017
Implementation of a Protocol Utilizing Adaptive CRT in a Normal AV Conduction, CRT Non-Response Population at Generator Replacement
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials

Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Improving Quality of Care in Child Mental Health Service Settings
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Orthopedics / Podiatry, Other Clinical Trial
Updated: 12/31/1969
Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Spinal Deformity Clinical Trial
Updated: 10/10/2017
Prospective, Multi-Center Adult Spinal Deformity Outcomes Database Registry
Status: Enrolling
Updated: 10/10/2017
Click here to add this to my saved trials

Spinal Deformity Clinical Trial
Updated: 10/10/2017
Prospective, Multi-Center Adult Spinal Deformity Outcomes Database Registry
Status: Enrolling
Updated: 10/10/2017
Click here to add this to my saved trials

Relapsing Multiple Scelrosis Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Relapsing Multiple Scelrosis Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
